Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Aprea reports Q2 2026 results, faster enrollment in APR-1051 trialAug 12Quarterly updateAPR-1051Aprea Therapeutics